EGFR/ALK/ROS1and TMB/MSI gene mutation detection data of 708 subjects from study HLX10-002-NSCLC301
| Title | EGFR/ALK/ROS1and TMB/MSI gene mutation detection data of 708 subjects from study HLX10-002-NSCLC301 |
|---|---|
| Description | EGFR/ALK/ROS1and TMB/MSI gene mutation detection data of 708 subjects from study HLX10-002-NSCLC301:A Three-Arm, Randomised, Double-Blind, Multicentre, Phase III Clinical Study to Evaluate HLX10 (Recombinant Humanised Anti-PD-1 Monoclonal Antibody Injection) in Combination with Chemotherapy (Carboplatin-Pemetrexed) Versus HLX10 + HLX04 (Recombinant Anti-VEGF Humanised Monoclonal Antibody Injection) in Combination with Chemotherapy (Carboplatin-Pemetrexed) Versus Chemotherapy (Carboplatin-Pemetrexed) as First-Line Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC). The purpose of this study was to evaluate the clinical efficacy, safety, and tolerability of HLX10 combined chemotherapy and HLX10+HLX04 combined chemotherapy versus chemotherapy in subjects who had not previously received systemic treatment for advanced non-squamous NSCLC, collect PK parameters, and explore biomarkers related to efficacy. |
| Organism | Homo sapiens |
| Data Type | Other Type of Genomic Data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA022783 |
| Release Date | 2024-01-12 |
| Submitter | xinyu Sun (xinyu_sun@henlius.com) |
| Organization | Shanghai Henlius Biotech,Inc. |
| Submission Date | 2024-01-11 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX005645-01 | HLX10-002-NSCLC301_EGFR ALK ROS1 TMB MSI gene mutation detection data of 708 subjects | 1 | Other Type of Genomic Data | 41.5 KB | xlsx | 0 | Controlled |